Remodeling of hepatic metabolism and hyperaminoacidemia in mice deficient in proglucagon-derived peptides

Diabetes

Volumn 61, Issue 1, 2012, Pages 74-84

  Watanabe, Chika ^a,b   Seino, Yusuke ^b   Miyahira, Hiroki ^a   Yamamoto, Michiyo ^a   Fukami, Ayako ^b   Ozaki, Nobuaki ^b   Takagishi, Yoshiko ^a   Sato, Jun ^a   Fukuwatari, Tsutomu ^c   Shibata, Katsumi ^c   Oiso, Yutaka ^b   Murata, Yoshiharu ^a   Hayashi, Yoshitaka ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF SHIGA PREFECTURE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCAGON GREEN FLUORESCENT PROTEIN; INSULIN; NICOTINAMIDE; PROGLUCAGON; PROTEIN KINASE B; PYRUVIC ACID; TRANSCRIPTOME; TRICARBOXYLIC ACID; UNCLASSIFIED DRUG;

AMINOACIDEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENERGY CONSUMPTION; FATTY ACID METABOLISM; FOOD INTAKE; GENE EXPRESSION; GLUCONEOGENESIS; INSULIN BLOOD LEVEL; LIPID METABOLISM; LIVER METABOLISM; MALE; METABOLOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

AMINO ACIDS; ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GREEN FLUORESCENT PROTEINS; LIPID METABOLISM; LIVER; MALE; METABOLIC DISEASES; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, BIOLOGICAL; PEPTIDE FRAGMENTS; PROGLUCAGON; UP-REGULATION;

EID: 84555195140     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-0739     Document Type: Article

References (45)

1. Kieffer TJ, Habener JF. The glucagon-like peptides. Endocr Rev 1999;20: 876-913 (Pubitemid 30647076)
2. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007;132:2131-2157 (Pubitemid 46711096)
3. Altarejos JY, Montminy M. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol 2011;12:141-151
4. Furuta M, Zhou A, Webb G, et al. Severe defect in proglucagon processing in islet A-cells of prohormone convertase 2 null mice. J Biol Chem 2001; 276:27197-27202
5. Gelling RW, Du XQ, Dichmann DS, et al. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci USA 2003;100:1438-1443 (Pubitemid 36184020)
6. Conarello SL, Jiang G, Mu J, et al. Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia. Diabetologia 2007;50:142-150 (Pubitemid 46035862)
7. Gagnon J, Mayne J, Chen A, et al. PCSK2-null mice exhibit delayed intestinal motility, reduced refeeding response and altered plasma levels of several regulatory peptides. Life Sci 2011;88:212-217
8. Gu W, Winters KA, Motani AS, et al. Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor. Am J Physiol Endocrinol Metab 2010; 299:E624-E632
9. Hayashi Y, Yamamoto M, Mizoguchi H, et al. Mice deficient for glucagon gene-derived peptides display normoglycemia and hyperplasia of islet alphacells but not of intestinal L-cells. Mol Endocrinol 2009;23:1990-1999
10. Futaki S, Hayashi Y, Yamashita M, et al. Molecular basis of constitutive production of basement membrane components. Gene expression profiles of Engelbreth-Holm-Swarm tumor and F9 embryonal carcinoma cells. J Biol Chem 2003;278:50691-50701 (Pubitemid 37548918)
11. Saito N, Ohashi Y, Soga T, Tomita M. Unveiling cellular biochemical reactions via metabolomics-driven approaches. Curr Opin Microbiol 2010;13: 358-362
12. Shimbo K, Kubo S, Harada Y, et al. Automated precolumn derivatization system for analyzing physiological amino acids by liquid chromatography/mass spectrometry. Biomed Chromatogr 2010;24:683-691
13. Fukuwatari T, Ohta M, Sugimoto E, Sasaki R, Shibata K. Effects of dietary di(2-ethylhexyl)phthalate, a putative endocrine disrupter, on enzyme activities involved in the metabolism of tryptophan to niacin in rats. Biochim Biophys Acta 2004;1672:67-75
14. Xue HH, Fujie M, Sakaguchi T, et al. Flux of the L-serine metabolism in rat liver. The predominant contribution of serine dehydratase. J Biol Chem 1999;274:16020-16027
15. Xue HH, Sakaguchi T, Fujie M, Ogawa H, Ichiyama A. Flux of the L-serine metabolism in rabbit, human, and dog livers. Substantial contributions of both mitochondrial and peroxisomal serine:pyruvate/alanine:glyoxylate aminotransferase. J Biol Chem 1999;274:16028-16033
16. Kimmich GA, Roussie JA, Randles J. Aspartate aminotransferase isotope exchange reactions: implications for glutamate/glutamine shuttle hypothesis. Am J Physiol Cell Physiol 2002;282:C1404-C1413 (Pubitemid 34663089)
17. Vitvitsky V, Mosharov E, Tritt M, Ataullakhanov F, Banerjee R. Redox regulation of homocysteine-dependent glutathione synthesis. Redox Rep 2003;8:57-63 (Pubitemid 36204255)
18. Hagopian K, Ramsey JJ, Weindruch R. Caloric restriction increases gluconeogenic and transaminase enzyme activities in mouse liver. Exp Gerontol 2003;38:267-278 (Pubitemid 36170321)
19. Jackson MJ, Beaudet AL, O'Brien WE. Mammalian urea cycle enzymes. Annu Rev Genet 1986;20:431-464
20. Deignan JL, Cederbaum SD, Grody WW. Contrasting features of urea cycle disorders in human patients and knockout mouse models. Mol Genet Metab 2008;93:7-14 (Pubitemid 350236003)
21. Merrill MJ, Pitot HC. Regulation of ornithine aminotransferase by cyclic AMP and glucose in primary cultures of adult rat hepatocytes. Arch Biochem Biophys 1985;237:373-385 (Pubitemid 15144891)
22. Savage DB, Choi CS, Samuel VT, et al. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J Clin Invest 2006;116: 817-824 (Pubitemid 43326891)
23. Kharitonenkov A, Shiyanova TL, Koester A, et al. FGF-21 as a novel metabolic regulator. J Clin Invest 2005;115:1627-1635 (Pubitemid 40814671)
24. Inagaki T, Dutchak P, Zhao G, et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab 2007;5:415-425 (Pubitemid 46825496)
25. Maeda K, Cao H, Kono K, et al. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab 2005;1:107-119 (Pubitemid 43960591)
26. Yan L, Otterness DM, Craddock TL, Weinshilboum RM. Mouse liver nicotinamide N-methyltransferase: cDNA cloning, expression, and nucleotide sequence polymorphisms. Biochem Pharmacol 1997;54:1139-1149 (Pubitemid 27479028)
27. Ishihara H, Maechler P, Gjinovci A, Herrera PL, Wollheim CB. Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells. Nat Cell Biol 2003;5:330-335 (Pubitemid 36432297)
28. Alenghat T, Meyers K, Mullican SE, et al. Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature 2008; 456:997-1000
29. Marliss EB, Aoki TT, Unger RH, Soeldner JS, Cahill GF Jr. Glucagon levels and metabolic effects in fasting man. J Clin Invest 1970;49:2256-2270
30. Boden G, Rezvani I, Owen OE. Effects of glucagon on plasma amino acids. J Clin Invest 1984;73:785-793 (Pubitemid 14156861)
31. Chastain MA. The glucagonoma syndrome: a review of its features and discussion of new perspectives. Am J Med Sci 2001;321:306-320 (Pubitemid 32428831)
32. Bewley AP, Ross JS, Bunker CB, Staughton RC. Successful treatment of a patient with octreotide-resistant necrolytic migratory erythema. Br J Dermatol 1996;134:1101-1104 (Pubitemid 26184474)
33. Alexander EK, Robinson M, Staniec M, Dluhy RG. Peripheral amino acid and fatty acid infusion for the treatment of necrolytic migratory erythema in the glucagonoma syndrome. Clin Endocrinol (Oxf) 2002;57:827-831 (Pubitemid 36963011)
34. Lee Y, Wang MY, Du XQ, Charron MJ, Unger RH. Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice. Diabetes 2011; 60:391-397
35. Ayala JE, Bracy DP, James FD, Julien BM, Wasserman DH, Drucker DJ. The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action. Endocrinology 2009;150:1155-1164
36. Liu Y, Dentin R, Chen D, et al. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 2008;456: 269-273
37. Kimball SR, Siegfried BA, Jefferson LS. Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase. J Biol Chem 2004;279:54103-54109 (Pubitemid 40053145)
38. Hara K, Yonezawa K, Weng QP, Kozlowski MT, Belham C, Avruch J. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J Biol Chem 1998;273: 14484-14494 (Pubitemid 28319170)
39. Tato I, Bartrons R, Ventura F, Rosa JL. Amino acids activate mammalian target of rapamycin complex 2 (mTORC2) via PI3K/Akt signaling. J Biol Chem 2011;286:6128-6142
40. Dennis MD, Baum JI, Kimball SR, Jefferson LS. Mechanisms involved in the coordinate regulation of mTORC1 by insulin and amino acids. J Biol Chem 2011;286:8287-8296
41. Longuet C, Sinclair EM, Maida A, et al. The glucagon receptor is required for the adaptive metabolic response to fasting. Cell Metab 2008;8:359-371
42. Rudling M, Angelin B. Stimulation of rat hepatic low density lipoprotein receptors by glucagon. Evidence of a novel regulatory mechanism in vivo. J Clin Invest 1993;91:2796-2805 (Pubitemid 23182538)
43. Imai S, Guarente L. Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol Sci 2010;31:212-220
44. Kennedy AR, Pissios P, Otu H, et al. A high-fat, ketogenic diet induces a unique metabolic state in mice. Am J Physiol Endocrinol Metab 2007;292: E1724-E1739 (Pubitemid 47084708)
45. Recinos A 3rd, Carr BK, Bartos DB, et al. Liver gene expression associated with diet and lesion development in atherosclerosis-prone mice: induction of components of alternative complement pathway. Physiol Genomics 2004;19:131-142 (Pubitemid 40039919)